4.4 Editorial Material

The emerging role of professional social media use in oncology

期刊

FUTURE ONCOLOGY
卷 13, 期 15, 页码 1281-1285

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/fon-2017-0161

关键词

communication; digital engagement; health information; health professionals; patient-physician relationships; professionalism; public health; social media; technology

类别

资金

  1. National Institutes of Health (NIH) National Cancer Institute (NCI) [K12CA001727]
  2. Phase One Foundation

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond

Rachel A. Freedman, Mina S. Sedrak, Jennifer R. Bellon, Caroline C. Block, Nancy U. Lin, Tari A. King, Christina Minami, Noam VanderWalde, Trevor A. Jolly, Hyman B. Muss, Eric P. Winer

Summary: Treatment decisions for older breast cancer patients are challenging during the COVID-19 pandemic, requiring a balance of treatment efficacy and risks, and promoting multidisciplinary care and team-based treatment.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Review Oncology

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

Mina S. Sedrak, Rachel A. Freedman, Harvey J. Cohen, Hyman B. Muss, Aminah Jatoi, Heidi D. Klepin, Tanya M. Wildes, Jennifer G. Le-Rademacher, Gretchen G. Kimmick, William P. Tew, Kevin George, Simran Padam, Jennifer Liu, Andrew R. Wong, Andrea Lynch, Benjamin Djulbegovic, Supriya G. Mohile, William Dale

Summary: Cancer is a disease of aging, and the number of older patients with cancer is increasing. However, older patients are underrepresented in cancer research and effective strategies to improve their participation in clinical trials are sparse. Studies on barriers and interventions for older adults in cancer trials are limited, highlighting a need for more evidence-based solutions to address this issue.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States

Taylor R. Cushman, Bernard Jones, David Akhavan, Chad G. Rusthoven, Vivek Verma, Ravi Salgia, Mina Sedrak, Erminia Massarelli, James W. Welsh, Arya Amini

Summary: The study aimed to investigate the impact of time from diagnosis to initial treatment on survival in patients with non-small cell lung cancer. Delayed treatment was associated with poorer survival outcomes and disparities based on race, ethnicity, and socioeconomic status in non-metastatic non-small cell lung cancer.

CLINICAL LUNG CANCER (2021)

Article Oncology

Growth of the Social #RadOnc Network on Twitter

Jennifer Novak, Yujie Cui, Paul Frankel, Mina S. Sedrak, Scott Glaser, Richard Li, Sabin Motwani, Brian Kavanagh, Arya Amini

Summary: This analysis characterizes the profile of radiation oncology-related tweets and Twitter users over the past 6 years, showing significant growth in tweet volume by physicians and academic radiation oncologists as primary influencers. Twitter is utilized for professional networking and discussions, with potential for broader audience reach, including patients.

PRACTICAL RADIATION ONCOLOGY (2021)

Article Oncology

Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer

Allison Magnuson, Mina S. Sedrak, Cary P. Gross, William P. Tew, Heidi D. Klepin, Tanya M. Wildes, Hyman B. Muss, Efrat Dotan, Rachel A. Freedman, Tracey O'Connor, William Dale, Harvey J. Cohen, Vani Katheria, Anait Arsenyan, Abrahm Levi, Heeyoung Kim, Supriya Mohile, Arti Hurria, Can-Lan Sun

Summary: The study identified 8 independent predictors and developed a scoring model to predict chemotherapy toxicity in older adults with early-stage breast cancer. Patients were classified into low, intermediate, and high-risk groups, aiding in the early prediction of toxic reactions.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer

Yuan Yuan, Jin Sun Lee, Susan E. Yost, Paul H. Frankel, Christopher Ruel, Colt A. Egelston, Weihua Guo, John D. Gillece, Megan Folkerts, Lauren Reining, Sarah K. Highlander, Kim Robinson, Simran Padam, Norma Martinez, Aileen Tang, Daniel Schmolze, James Waisman, Mina Sedrak, Peter P. Lee, Joanne Mortimer

Summary: The study investigated the safety and efficacy of the combination of enobosarm and pembrolizumab in patients with AR+ metastatic TNBC. Despite showing a modest clinical benefit rate, the trial was stopped early due to the withdrawal of drug supply.

ONCOLOGIST (2021)

Article Oncology

Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer

Yanin Chavarri-Guerra, Catherine A. Marcum, Carolyn B. Hendricks, Deborah Wilbur, Terrence Cescon, Christopher Hake, Julio Abugattas, Yenni Rodriguez, Cynthia Villarreal-Garza, Kai Yang, Aleck Cervantes, Sharon Sand, Danielle Castillo, Joseph Herzog, Janet Mokhnatkin, Mina S. Sedrak, Enrique Soto-Perez-de-Celis, Jeffrey N. Weitzel

Summary: This study found that a significant proportion of women aged over 60 with triple negative breast cancer have pathogenic variants associated with breast cancer, including BRCA1 and BRCA2. The results suggest that older patients should also be offered genetic testing and not be excluded based solely on their age.

JOURNAL OF GERIATRIC ONCOLOGY (2021)

Article Neuroimaging

Effect of chemotherapy on default mode network connectivity in older women with breast cancer

Bihong T. Chen, Zikuan Chen, Sunita K. Patel, Russell C. Rockne, Chi Wah Wong, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei Holodny, Can-Lan Sun, Mina S. Sedrak, Heeyoung Kim, Ashley Celis, Vani Katheria, William Dale

Summary: Chemotherapy in older women with breast cancer can lead to alterations in the connectivity of the default mode network, with a pattern of stronger anterior connectivity and weaker posterior connectivity observed post-chemotherapy. These changes may serve as potential neuroimaging biomarkers for cancer-related cognitive impairment and accelerated aging.

BRAIN IMAGING AND BEHAVIOR (2022)

Article Health Care Sciences & Services

Evaluating Scholars' Impact and Influence: Cross-sectional Study of the Correlation Between a Novel Social Media-Based Score and an Author-Level Citation Metric

Lucas Oliveira J. E. Silva, Graciela Maldonado, Tara Brigham, Aidan F. Mullan, Audun Utengen, Daniel Cabrera

Summary: This study revealed a weak positive correlation between a novel author-level complementary metric and the h-index, suggesting a bridge between the traditional citation metrics and novel social media-based metrics.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Article Oncology

Multimodality Treatment with Radiotherapy and Immunotherapy in Older Adults: Rationale, Evolving Data, and Current Recommendations

Elizabeth A. A. Germino, Ameish Govindarajan, Mina S. S. Sedrak, Daneng Li, Arya Amini

Summary: The combination of immunotherapy and radiotherapy/chemoradiation has shown promising results in certain cancer patients. However, there are challenges in translating this combination therapy into real-world practice, as clinical trials often do not include a representative sample of older adults with comorbidities who make up a significant proportion of patients in clinical settings. This review aims to provide an overview of the current evidence for multimodality treatment in older adults, including extrapolation from single-modality therapies, and to highlight ongoing trials targeting older cancer patients. The review identifies current gaps in the field and provides recommendations for considering these gaps in both preclinical settings and when designing clinical trials, in order to improve the use of multimodality therapy in clinical practice as more data becomes available.

SEMINARS IN RADIATION ONCOLOGY (2022)

Article Neurosciences

Signal Variability and Cognitive Function in Older Long-Term Survivors of Breast Cancer with Exposure to Chemotherapy: A Prospective Longitudinal Resting-State fMRI Study

Bihong T. Chen, Zikuan Chen, Frank Deng, Sunita K. Patel, Mina S. Sedrak, James C. Root, Tim A. Ahles, Marianne Razavi, Heeyoung Kim, Can-Lan Sun, William Dale

Summary: This study aimed to investigate the impact of chemotherapy on brain functional resting-state signal variability and cognitive function in older long-term survivors of breast cancer. The findings revealed a significant decrease in SDBOLD in the CH group, indicating potential alterations in brain function in breast cancer survivors exposed to chemotherapy.

BRAIN SCIENCES (2022)

Article Neuroimaging

Cortical thinning in chemotherapy-treated older long-term breast cancer survivors

Ebenezer Daniel, Frank Deng, Sunita K. Patel, Mina S. Sedrak, Heeyoung Kim, Marianne Razavi, Can-Lan Sun, James C. Root, Tim A. Ahles, William Dale, Bihong T. Chen

Summary: This study aimed to evaluate alterations in cortical thickness and cognition in older long-term survivors of breast cancer who had been treated with chemotherapy. The results showed that long-term chemotherapy could lead to cortical thinning and cognitive decline in older cancer survivors.

BRAIN IMAGING AND BEHAVIOR (2023)

Article Medicine, General & Internal

Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer

Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. E. Mortimer

Summary: Glucocorticoids administered with chemotherapy cause hyperglycemia in breast cancer patients. A retrospective study analyzed random blood glucose levels in early-stage breast cancer patients who received dexamethasone prior to chemotherapy. The incidence of steroid-induced hyperglycemia (SIH) was 67%, and it was highest in patients with glucose levels of >200 mg/dL. Non-Hispanic White patients had a higher risk of developing SIH, but over 90% of the patients had transient hyperglycemia.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Gastroenterology & Hepatology

Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool Among Patients With Neuroendocrine Tumors

Daneng Li, Giovanna J. Imbesi, Lisa Yen, Heeyoung Kim, Can-Lan Sun, Christiana J. Crook, Richard Ballena, Ya-Han Zhang, Rebecca Allen, Mina Sedrak, Gagandeep Singh

Summary: There is a lack of effective patient education about the diagnosis and treatment of neuroendocrine tumors (NETs), possibly due to their rare occurrence. In this study, a self-assessment tool called NET VITALS was used to evaluate patients' perception and awareness of their NET diagnosis and treatment. The results revealed a lack of knowledge among patients regarding tumor characteristics, symptoms duration, and liver-directed therapies. Additionally, a significant proportion of patients felt that they did not receive sufficient information about NETs at the time of diagnosis. However, most patients found NET VITALS helpful in discussing topics with healthcare providers and would recommend it to others.

PANCREAS (2022)

暂无数据